
Kinase activity profiles as prognostic marker for immunotherapy in head and neck squamous cell carcinoma (HNSCC)
Author(s) -
Lara Bußmann,
Konstantin Hoffer,
CS Betz,
C-J Busch,
Adrian Münscher,
Gunnar Hapke,
Malte Kriegs
Publication year - 2021
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0041-1727984
Subject(s) - cetuximab , medicine , immunotherapy , oncology , head and neck squamous cell carcinoma , antibody , immune system , radiation therapy , cisplatin , head and neck cancer , cancer research , chemotherapy , monoclonal antibody , immunology , cancer